Critical Appraisal of Enteral Nutrition as Primary Therapy in Adults with Crohn's Disease

Bernstein, Charles N.; Shanahan, Fergus
October 1996
American Journal of Gastroenterology;Oct1996, Vol. 91 Issue 10, p2075
Academic Journal
Focuses on the nutritional therapies used in treating patients with Crohn's disease. Use of enteral nutrition therapy for pediatric patients; Advantage of enteral nutrition over parenteral nutrition; Effect of elemental nutrition on intestinal integrity and permeability.


Related Articles

  • Nutritional therapy for Crohn's disease in Japan. Matsui, Toshiyuki; Sakurai, Tosfiihiro; Yao, Tsuneyoshi // Journal of Gastroenterology;Apr2005 Supplement 16, Vol. 40, p25 

    In Japan, nutritional therapy as both a primary and as a secondary treatment is widely used for Crohn's disease (CD). The rationale for its use is based on a variety of reasons. The first is its ability to induce remission and to ameliorate the activity of intestinal lesions in the short term by...

  • Positive impact of blocking tumor necrosis factor α on the nutritional status in pediatric Crohn’s disease patients. Diamanti, A.; Basso, M. S.; Gambarara, M.; Papadatou, B.; Bracci, F.; Noto, C.; Castro, M. // International Journal of Colorectal Disease;Jan2009, Vol. 24 Issue 1, p19 

    TNFα seems to contribute to inflammation and malnutrition in Crohn’s disease (CD) patients. In CD patients, the comparative effects on nutritional status of infliximab and traditional therapy have not yet been determined. The aim of our study was to assess the effects of infliximab as...

  • Thalidomide improves clinical remission in children with Crohn's disease. Harbour, Sophie; Brown, Nick // Archives of Disease in Childhood -- Education & Practice Edition;Apr2014, Vol. 100 Issue 2, p111 

    The article discusses a study which investigates the efficacy of thalidomide in treating Crohn's disease in children. Topics covered include the use of six paediatric tertiary care centers in Italy between August 2008 and September 2012 as the study's setting, the administration of thalidomide...

  • Continuing Medical Education Questions. Scolapio, James S.; Qadeer, Mohammed A; Levitzky, Benjamin; Marrero, Frank // American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2813 

    If you wish to receive credit for this activity, please refer to the Web site: Article Title:Methotrexate Following Unsuccessful Thiopurine Therapy in Pediatric Crohn's Disease

  • Methotrexate Following Unsuccessful Thiopurine Therapy in Pediatric Crohn's Disease. Turner, Dan; Grossman, Andrew B.; Rosh, Joel; Kugathasan, Subra; Gilman, Ashley R.; Baldassano, Robert; Griffiths, Anne M. // American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2804 

    BACKGROUND: The thiopurines, azathioprine and 6-mercaptopurine, are traditional first-line immunomodulatory agents in adult and pediatric Crohn's disease, but the comparative efficacy and safety of methotrexate have seldom been examined. We report outcomes with methotrexate treatment in...

  • Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease A Randomized Clinical Trial. Lazzerini, Marzia; Martelossi, Stefano; Magazzù, Giuseppe; Pellegrino, Salvatore; Lucanto, Maria Cristina; Barabino, Arrigo; Calvi, Angela; Arrigo, Serena; Lionetti, Paolo; Lorusso, Monica; Mangiantini, Francesca; Fontana, Massimo; Zuin, Giovanna; Palla, Gabriella; Maggiore, Giuseppe; Bramuzzo, Matteo; Pellegrin, Maria Chiara; Maschio, Massimo; Villanacci, Vincenzo; Manenti, Stefania // JAMA: Journal of the American Medical Association;11/27/2013, Vol. 310 Issue 20, p2164 

    IMPORTANCE Pediatric-onset Crohn disease is more aggressive than adult-onset disease, has high rates of resistance to existing drugs, and can lead to permanent impairments. Few trials have evaluated new drugs for refractory Crohn disease in children. OBJECTIVE To determine whether thalidomide is...

  • Genotype/Phenotype Analyses for 53 Crohn's Disease Associated Genetic Polymorphisms. Jung, Camille; Colombel, Jean-Frédéric; Lemann, Marc; Beaugerie, Laurent; Allez, Matthieu; Cosnes, Jacques; Vernier-Massouille, Gwenola; Gornet, Jean-Marc; Gendre, Jean-Pierre; Cezard, Jean-Pierre; Ruemmele, Frank M.; Turck, Dominique; Merlin, Françoise; Zouali, Habib; Libersa, Christian; Dieudé, Philippe; Soufir, Nadem; Thomas, Gilles; Hugot, Jean-Pierre // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Background & Aims: Recent studies reported a role for more than 70 genes or loci in the susceptibility to Crohn's disease (CD). However, the impact of these associations in clinical practice remains to be defined. The aim of the study was to analyse the relationship between genotypes and...

  • Continuing Medical Education: December 2007.  // American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2803 

    Methotrexate Following Unsuccessful Thiopurine Therapy in Pediatric Crohn's Disease Accreditation and Designation Statement: Blackwell Futura Media Services designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Awardâ„¢. Each...

  • Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease. Luthra, Gurinder; Pasricha, P. Jay // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p92 

    Comments on a study which discovered that olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis. Comparison of the effects of olsalazine and placebo on patients; Assessment of adverse events in patients; Effects of mesalamine on patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics